Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Axial Spondyloarthritis

Treating Early-Stage Spondyloarthritis May Prevent Disease Progression, Say Researchers at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff  |  April 2, 2014

Therapy with tumor necrosis factor inhibitors, nonsteroidal antiinflammatory drugs, ustekinumab in early stages of osteitis may halt molecular switching to bone-forming phenotype characteristic of SpA

Approval Expected for Apremilast

Richard Quinn  |  March 5, 2014

New drug shows promise in treating psoriatic arthritis, ankylosing spondylitis & psoriasis

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

Paleopathology Uses Patients from the Past to Investigate Today’s Diseases

Bruce Rothschild, MD  |  February 1, 2014

Evidence of disease in prehistoric skeletons can provide clues to early characteristics of rheumatoid arthritis, calcium pyrophosphate deposition disease, and other joint disorders

Does Anti-Tumor Necrosis Factor-Alpha Increase Cardiovascular Burden?

Lara C. Pullen, PhD  |  January 14, 2014

Long-term use of TNFα inhibitors in patients with rheumatoid arthritis and ankylosing spondylitis is associated with both gains in fat mass and a shift in fat mass to the visceral region.  (posted Jan. 14)

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  January 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

Fellow’s Forum Case Report: Arthritis, Fever, and Weight Loss In a Teenager Suggest A Rheumatic Condition

Jonathan S. Hausmann, MD  |  January 1, 2014

Joint pain and swelling flare up in a 14-year-old boy who tests positive for inflammation, thrombocytosis, and human leukocyte antigen B27

Tips for Rheumatologists to Prevent, Alleviate Back Pain in Patients with Rheumatic Disease

Kimberly Retzlaff  |  November 1, 2013

A multidisciplinary approach that incorporates an exercise program, physical therapy, and ways to maintain good posture and a healthy weight can help patients find relief

Physician Maxime Dougados, MD, Is Intent on Advancing Clinical Measurement in Rheumatology

Gretchen Henkel  |  September 1, 2013

Visionary rheumatologist credited with developing new spondylarthritis criteria, collaborating on the OASIS study, and promoting the 3E Initiative in rheumatology

EULAR 2013: Drugs New and Old Could Treat Spondylarthropies

Thomas R. Collins  |  September 1, 2013

Nonsteroidal anti-inflammatory drugs (NSAIDs) might still have a role in treating axial spondylarthritis, but other drugs, therapies are being explored

  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 19
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences